ConjuGon

'Failed' experiment yields a biocontrol agent that doesn't trigger antibiotic resistance

...oncology Richard Burgess, started a company called conjugon - "because you conjugate and it's gone!" -- to dev...h park company themselves, but they are proud that conjugon employs other people and has created 12 high-payin...adison area. Because of that, says Filutowicz, conjugon is helping to ensure the future of microbial scien...

ConjuGon in Biological Technology

ConjuGon Awarded $250,000

... proprietary technology for treating and preventing bacterial infections. The Technology Development Fund is a spectacular asset to Wisconsin, said conjugon president Marcin Filutowicz. We are fortunate that our state recognizes the long-term benefit of cultivating our Wisconsin businesses and keeping our ...

WARF Granted New Antibiotics Patent

... Madison conjugon announces today that the U.S. Patent and Trade Of...nt agency of the University of Wisconsin-Madison. conjugon has an exclusive license to this important intelle...f Wisconsin-Madison research group, which included conjugon scientist Larry Anthony. This patent could lead t...

ConjuGon to present at Sachs-Bloomberg Global Biotech Forum

...hs-Bloomberg Global Biotech Forum for Investing & Partnering has selected conjugon to present at its forum in Boston, April 1-2. The conference is designed t...well as various keynote speakers. A total of 50 companies will present. For conjugon and the other selected companies, attending the forum presents an opportuni...

ConjuGon receives $500,000 to battle bacteria

...s and $290,000 in economic development loans from the Madison Development Corporation and the Wisconsin Department of Commerce . Madison-based conjugon is developing therapeutics to combat antibiotic-resistant bacterial infections, a growing medical concern. Based on University of Wisconsin-Madison re...

ConjuGon lands $1 million angel investment

...nter at University Research Park. Madison, Wis. Medical research group conjugon announced on Tuesday that they have successfully secured an investment of ...cesses to the skills of Christopher Price, who recently joined the staff of conjugon as CEO, as well as improvements to their core technology for antibacterial ...

Tech Digest: whats moving in the Midwest

...GE Healthcare profits up 31 percent for quarter conjugon CEO to speak on both coasts UW center to make C... MRI scanner with the University of Illinois. conjugon CEO to speak on both coasts The medical research firm conjugon announced on Monday that CEO Christopher Price wil...

BIO provides forum for Wisconsin to showcase strengths

...over creating lots of new ones. Sal Braico, chief operating officer at conjugon , said that they will be attending several of the major partnering sessions...anies are headquartered in Philadelphia, so medical research companies like conjugon may have an easier time developing partnerships. "We don't have many big...

Six Wisconsin firms to present at BIO Mid-America VentureForum

...ico, chief operating officer of the antibiotic resistance research company conjugon , said conjugon typically attends four to five conferences such as BIO each year and always...

Mithridion raises $1.6M through angel networks

...rincipal Paul Evans said he connected with Twose through Richard Burgess , a professor at UW-Madison and co-founder of Madison biotech firm ConjuGon. conjugon was Rosetta's first investment in Wisconsin. The next round of funding Mithridion needs will probably be around $4 million and come from venture ca...

ConjuGon raises $3.3 million to fund clinical trials

...any, has raised $3.3 million in an investment round led by Rosetta Partners, a private investment firm based in Lake Forest, Ill. The Madison-based conjugon will use the capital for clinical trials of its treatment for the infections of large wounds, and to fund the development and testing of its core tech...

More>>